Fostemsavir Active in Multidrug-Resistant HIV-1 Infection
Reduction in HIV-1 RNA level significantly greater for fostemsavir versus placebo in randomized cohort
Reduction Noted in Transfusion Burden With Luspatercept
Reduction seen with luspatercept versus placebo for patients with transfusion-dependent β-thalassemia
Gilead Backs Down on Special Designation for Possible COVID-19 Drug
Pharmaceutical company had asked the FDA to designate remdesivir an 'orphan drug'
Workers at Risk for COVID-19 Exposure Can Access Online Training
The National Institute of Environmental Health Sciences launched virtual training website to protect workers
ACC: Statins Cut Heart Failure Risk in Early Breast Cancer Treatment
Risk for heart failure hospital visit declined with statins for women receiving anthracyclines, trastuzumab
Proton Pump Inhibitors May Up Fracture Risk in Children
Small but significant risk seen for upper-limb and lower-limb fractures
Many Older Adults Receive Inpatient Diabetes Rx Intensification
Benefit unlikely in half due to limited life expectancy or already being at their HbA1c goal
National Health Spending Expected to Increase Through 2028
National health expenditures expected to represent 19.7 percent of gross domestic product by 2028
FDA Warns of Defective EpiPen Dangers
Devices may activate prematurely if the blue safety release is removed using sideways force
Daily Low-Dose Aspirin Does Not Cut Dementia Risk in Seniors
Risks for dementia, probable Alzheimer disease, MCI not reduced by low-dose aspirin versus placebo
